Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $137.40 million. The enterprise value is $62.65 million.
Important Dates
The last earnings date was Wednesday, March 12, 2025, after market close.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 186.10 million shares outstanding. The number of shares has increased by 8.24% in one year.
| Current Share Class | 186.10M |
| Shares Outstanding | 186.10M |
| Shares Change (YoY) | +8.24% |
| Shares Change (QoQ) | +2.08% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 66.66% |
| Float | 173.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.54 |
| Forward PS | 1.67 |
| PB Ratio | 2.26 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 3.20.
| Current Ratio | 4.26 |
| Quick Ratio | 4.18 |
| Debt / Equity | 3.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.62 |
Financial Efficiency
Return on equity (ROE) is -124.10% and return on invested capital (ROIC) is -26.34%.
| Return on Equity (ROE) | -124.10% |
| Return on Assets (ROA) | -23.14% |
| Return on Invested Capital (ROIC) | -26.34% |
| Return on Capital Employed (ROCE) | -53.59% |
| Revenue Per Employee | $1.61M |
| Profits Per Employee | -$1.95M |
| Employee Count | 61 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -239,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.59% in the last 52 weeks. The beta is 0.65, so NKTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -16.59% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 36.37 |
| Average Volume (20 Days) | 1,459,330 |
Short Selling Information
The latest short interest is 6.95 million, so 3.73% of the outstanding shares have been sold short.
| Short Interest | 6.95M |
| Short Previous Month | 6.62M |
| Short % of Shares Out | 3.73% |
| Short % of Float | 3.99% |
| Short Ratio (days to cover) | 3.38 |
Income Statement
In the last 12 months, NKTR had revenue of $98.43 million and -$118.96 million in losses. Loss per share was -$0.58.
| Revenue | 98.43M |
| Gross Profit | 67.74M |
| Operating Income | -129.92M |
| Pretax Income | -177.16M |
| Net Income | -118.96M |
| EBITDA | -125.53M |
| EBIT | -129.92M |
| Loss Per Share | -$0.58 |
Full Income StatementBalance Sheet
The company has $255.23 million in cash and $194.34 million in debt, giving a net cash position of $74.76 million or $0.40 per share.
| Cash & Cash Equivalents | 255.23M |
| Total Debt | 194.34M |
| Net Cash | 74.76M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 60.74M |
| Book Value Per Share | 0.33 |
| Working Capital | 199.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$175.71 million and capital expenditures -$1.47 million, giving a free cash flow of -$177.18 million.
| Operating Cash Flow | -175.71M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -177.18M |
| FCF Per Share | -$0.95 |
Full Cash Flow StatementMargins
Gross margin is 68.82%, with operating and profit margins of -131.99% and -120.86%.
| Gross Margin | 68.82% |
| Operating Margin | -131.99% |
| Pretax Margin | -121.10% |
| Profit Margin | -120.86% |
| EBITDA Margin | -127.53% |
| EBIT Margin | -131.99% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.24% |
| Shareholder Yield | n/a |
| Earnings Yield | -86.58% |
| FCF Yield | -128.95% |
Analyst Forecast
The average price target for NKTR is $5.50, which is 644.96% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 644.96% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 9.95% |
| EPS Growth Forecast (5Y) | 1.47% |
Stock ForecastsStock Splits
The last stock split was on August 23, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 23, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
NKTR has an Altman Z-Score of -16.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.35 |
| Piotroski F-Score | 3 |